CLINICAL TRIALS TO ADVANCE THERAPIES FOR CARDIOVASCULAR DISEASE IN TYPE 1 DIABETES
Up to a total of $3,000,000 USD for up to three years. - Wednesday October 29, 2025 (LOI)
Breakthrough T1D, USBreakthrough T1D invites applications for clinical trials to advance therapies to improve CVD outcomes in T1D.
